Endoscopy Clinical Trials

Clinical trials related to Endoscopy Procedure

Comparison of Advanced Hemodynamic Monitoring With Standard Monitoring During Propofol Sedation in ERCP Procedures: A Prospective Observational Study

Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Observational
SUMMARY

The aim of this study is to evaluate whether there is a difference in hemodynamic events requiring intervention between patients monitored with advanced hemodynamic monitoring using the MostCare system and those monitored with standard monitoring alone during propofol sedation for ERCP procedures.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 years and older

• Patients with an ASA physical status score of III or higher scheduled for ERCP

• Patients maintaining spontaneous respiration

• Patients who have provided written informed consent

Locations
Other Locations
Turkey
Hitit university
RECRUITING
Çorum
Contact Information
Primary
Sibel Onen Ozdemir, MD
sibelonen89@gmail.com
+905442892194
Time Frame
Start Date: 2026-03-27
Estimated Completion Date: 2026-07-15
Participants
Target number of participants: 32
Treatments
Group 1 - Standard Monitoring Group
In this group, sedation depth will be monitored using non-invasive arterial blood pressure (NIBP), electrocardiography (ECG), pulse oximetry (SpO₂), and BIS. Arterial cannulation and advanced hemodynamic monitoring will not be applied.
Group 2 - Advanced Hemodynamic Monitoring Group
In addition to standard monitoring parameters, radial arterial cannulation will be performed, and advanced hemodynamic variables including cardiac output (CO), cardiac index (CI), stroke volume (SV), stroke volume index (SVI), systemic vascular resistance and systemic vascular resistance index (SVR), arterial elastance (Ea), cardiac cycle efficiency (CCE), and cardiac power output (CPO) will be monitored using the MostCare system (Vygon, Italy).
Related Therapeutic Areas
Sponsors
Leads: Hitit University

This content was sourced from clinicaltrials.gov